Vistagen Therapeutics Inc (VTGN) Finds Stem Cell Partner In Bayer AG (ADR) (BAYRY) With Phase II TRD Data On Tap

We last covered Vistagen Therapeutics Inc (NASDAQ:VTGN) back in September, focusing primarily on its flagship AV-101 for treatment-resistant depression (TRD).

Keep Reading →